Ginkgo Bioworks Holdings, Inc. (DNA) Stock Grade

About Ginkgo Bioworks Holdings, Inc.'s fundamentals

Ginkgo Bioworks is a mid-sized biotech company with a market capitalization of $460.9 million that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of -183.8%. The company experienced a significant contraction in revenue, declining 25.1% year-over-year, indicating shrinking sales despite its position in the biotechnology sector. With no dividend yield and negative profitability metrics, the company is not yet generating returns for shareholders through dividends or earnings.